Back to Search
Start Over
Where Do We See Alpha Emitters in Clinical Practice? A Radiation Oncology Perspective
- Source :
- O'Sullivan, J M 2019, ' Where Do We See Alpha Emitters in Clinical Practice? A Radiation Oncology Perspective ', Journal of Medical Imaging and Radiation Sciences, vol. 50, no. 4, Supplement 1, pp. S31-S33 . https://doi.org/10.1016/j.jmir.2019.06.044
- Publication Year :
- 2019
- Publisher :
- Elsevier BV, 2019.
-
Abstract
- Alpha emitters have always promised to deliver potential benefit in cancer therapy. Using the example of radium-223 (Xofigo) and the paradigm of ionising radiation, this review looks at targeted alpha therapy from the perspective of a radiation oncologist.
- Subjects :
- Male
medicine.medical_specialty
Cancer therapy
Alpha (ethology)
Targeted alpha therapy
030218 nuclear medicine & medical imaging
Ionizing radiation
03 medical and health sciences
Prostate cancer
0302 clinical medicine
SDG 3 - Good Health and Well-being
Radiation oncology
Humans
Medicine
Radiology, Nuclear Medicine and imaging
Medical physics
Radiation oncologist
Radioisotopes
Radiological and Ultrasound Technology
business.industry
Perspective (graphical)
Prostatic Neoplasms
prostate cancer
Alpha Particles
medicine.disease
Clinical Practice
Radiology Nuclear Medicine and imaging
030220 oncology & carcinogenesis
Radiation Oncology
business
Radium
Subjects
Details
- ISSN :
- 19398654
- Volume :
- 50
- Database :
- OpenAIRE
- Journal :
- Journal of Medical Imaging and Radiation Sciences
- Accession number :
- edsair.doi.dedup.....5dd416172353cf967f062b5f838fb87a